We are pleased to announce that Dr. Zhou has been invited by the National Institutes of Health (NIH) Center for Scientific Review (CSR) to serve as an Early Career Reviewer (ECR) for the Innovations in Nanosystems and Nanotechnology (INN) Study Section. The INN Study Section reviews innovative research applications in nanotechnology, biomaterials, drug and gene delivery, and related biomedical technologies. This invitation recognizes Dr. Zhou’s expertise in RNA nanomedicine, targeted lipid nanoparticle (LNP) delivery, and nanotherapeutic development for lung inflammation and vascular disorders. Participation in the NIH Early Career Reviewer Program provides an opportunity to contribute to the NIH peer review process while gaining valuable experience in the evaluation of cutting-edge biomedical research proposals. We are honored by this recognition and look forward to contributing to the NIH scientific review community.